BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Big Pharma Giant Kicks Off Q1 Earnings After Hiking Prices More Than 40 Times in 2023 This week, brand name drug giant Johnson & Johnson kicked off the first round of Big Pharma earnings calls for the first quarter of 2024. The company surpassed Wall Street analysts’ earnings expectations after hiking prescription drug prices more
0 CommentsComment on Facebook